Cargando…
Urinary 6-sulfatoxymelatonin level and breast cancer risk: systematic review and meta-analysis
6-Sulfatoxymelatonin (aMT6s) is the main metabolite of melatonin in urine, and is a reliable surrogate biomarker reflecting the blood melatonin concentration. This meta-analysis assessed the association between urinary aMT6s level and BC incidence. The electronic databases PubMed, EMBASE, Cochrane L...
Autores principales: | Xu, Jing, Huang, Lei, Sun, Guo-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509698/ https://www.ncbi.nlm.nih.gov/pubmed/28706222 http://dx.doi.org/10.1038/s41598-017-05752-9 |
Ejemplares similares
-
Urinary 6-sulfatoxymelatonin level in girls and its relationship with obesity
por: Lee, Jieun, et al.
Publicado: (2012) -
Urinary 6-sulfatoxymelatonin level in age-related macular degeneration patients
por: Rosen, Richard, et al.
Publicado: (2009) -
Intense solar activity reduces urinary 6-sulfatoxymelatonin in patients with COPD
por: Zilli Vieira, Carolina L., et al.
Publicado: (2023) -
Lower nocturnal urinary 6-sulfatoxymelatonin is associated with more severe insulin resistance in patients with prediabetes
por: Reutrakul, Sirimon, et al.
Publicado: (2017) -
Male-female differences in 6-sulfatoxymelatonin excretion in hypopituitary patients
por: Fideleff, Hugo L., et al.
Publicado: (2015)